Revolution Medicines, Inc. (RVMD): The Biotech Stock With Biggest Upside Potential

Yahoo FinanceJan 18 00:24

Barclays Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $72

Futu NewsJan 16 18:31 · Ratings

Barclays Reaffirms Their Buy Rating on Revolution Medicines (RVMD)

TipRanksJan 16 18:18 · Ratings

Unusual Options Activity: NXPI, TSM and Others Attract Market Bets, NXPI V/OI Ratio Reaches 145.5

EST Jan 15th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options

Futu NewsJan 16 05:30

BofA Securities Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $80

Futu NewsJan 14 20:36 · Ratings

Analysts' Top Healthcare Picks: Envista Holdings (NVST), Revolution Medicines (RVMD)

TipRanksJan 12 17:30 · Ratings